Hearing loss is a significant public health problem affecting close to 50 million people in the United States alone. Sensorineural hearing loss is the most common form and is caused by the loss of sensory hair cells in the ...
Jan 9, 2013
16
4
CAMH-led pre-clinical studies using a small molecule drug have shown promise as a potential new treatment for multiple sclerosis (MS). The results have been published in the journal Science Advances.
Dec 8, 2023
0
237
Effective hearing loss treatments have eluded medicine because once sensory cells in the inner ear called hair cells are damaged or destroyed, they cannot be regenerated. This loss of hair cells, which can be caused by aging, ...
Apr 18, 2023
2
71
Several NGOs protested Thursday at the annual meeting of Novartis against the attempt by the Swiss pharmaceutical group's India company to obtain a patent for its anti-cancer drug Glivec.
Feb 23, 2012
0
0
Despite decades of research and tens of billions of dollars for research and treatments worldwide, the battle against cancer continues.
Implantable devices that release insulin into the body hold promise as an alternative way to treat diabetes without insulin injections or cannula insertions. However, one obstacle that has prevented their use so far is that ...
Aug 5, 2022
0
99
Despite the limited supply of organs available for patients on waitlists for transplantation, organs from older, deceased donors are frequently discarded or not utilized. Available older organs have the potential to close ...
Aug 27, 2020
0
317
(Medical Xpress) -- Researchers at the Georgia Tech Research Institute (GTRI) have developed a novel iPhone application that may enable persons with Parkinson's disease and certain other neurological conditions to use the ...
Jun 23, 2011
0
0
Something like a quarter of the world's population suffers from chronic pain at some point in their lives. As opposed to acute pain—for example, the feeling after hitting your finger with a hammer—chronic pain may not ...
Aug 19, 2020
0
279
A newly engineered peptide called IBP-CP24 has the potential to be further developed as a long-acting anti-HIV drug that can be used alone or in combination with a broad neutralizing antibody for the treatment and prevention ...
Dec 5, 2019
0
4
